BioCryst Pharma (BCRX) Prices 37.93M Share Common Offering at $1.45/Sh

Pre-Open Movers 11/13: (CDLX) (CHK) (TWOU) Higher; (APDN) (SSTI) (SDC) Lower (more...)

Today's Pre-Open Movers

Applied DNA Sciences, Inc. (NASDAQ: APDN) 75.6% LOWER; announced the pricing of an underwritten public offering of 2,285,000 shares of its common stock and warrants to purchase up to an aggregate of 2,285,000 shares of common stock. Each share of common stock is being sold together with one warrant to purchase one share of common stock at a combined effective price to the public of $5.25 per share and accompanying warrant. Gross proceeds, before underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $12.0 million, not including any... More

After-Hours Movers 11/12: (CLDX) (TWOU) (DDOG) Higher; (SSTI) (SDC) (CSIQ) Lower (more...)

Today's After-Hours Movers

Cardlytics (NASDAQ: CDLX) 22.6% HIGHER; reported Q3 EPS of $0.03, $0.18 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $56.4 million versus the consensus estimate of $50.06 million. Cardlytics sees Q4 2019 revenue of $55-59 million, versus the consensus of $55.74 million. Cardlytics sees FY2019 revenue of $195-200 million, versus the consensus of $190.49 million.

2u (NASDAQ: TWOU) 14.4% HIGHER; reported Q3 EPS of ($0.41), $0.09 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $153.8 million versus the consensus... More

BioCryst Pharma (BCRX) Commences $55M Public Offering of Common Stock

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today that it is offering to sell $55 million of its common stock in an underwritten public offering. As part of this offering, BioCryst intends to grant the underwriters a 30-day option to purchase up to an additional $8.25... More